Transforming growth factor-β1 plasma levels in stable renal allograft recipients under different immunosuppression [4] (multiple letters)

Transplantation

Volumn 71, Issue 4, 2001, Pages 586-587

  Hetzel, Gerd R ^a,b,c   Plum, Jörg ^a,b   Özcan, Fedai ^a,b   Heering, Peter ^a,b   Grabensee, Bernd ^a,b  

^a Department of Nephrology and Rheumatology ^*  (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Klinik Fu'r Nephrologie und Rheumatologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; BLOOD LEVEL; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035956981     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200102270-00022     Document Type: Letter

References (0)